Literature DB >> 20206291

Cadmium chloride, benzo[a]pyrene and cyclophosphamide tested in the in vitro mammalian cell micronucleus test (MNvit) in the human lymphoblastoid cell line TK6 at Covance laboratories, Harrogate UK in support of OECD draft Test Guideline 487.

Paul Fowler1, James Whitwell, Laura Jeffrey, Jamie Young, Katie Smith, David Kirkland.   

Abstract

The following genotoxic chemicals were tested in the in vitro micronucleus assay, at Covance Laboratories, Harrogate, UK in the human lymphoblastoid cell line TK6. Cadmium chloride (an inorganic carcinogen), benzo[a]pyrene (a polycyclic aromatic hydrocarbon requiring metabolic activation) and cyclophosphamide (an alkylating agent requiring metabolic activation) were treated with and without cytokinesis block (by addition of cytochalasin B). This work formed part of a collaborative evaluation of the toxicity measures recommended in the draft OECD Test Guideline 487 for the in vitro micronucleus test. The toxicity measures used, capable of detecting both cytostasis and cell death, were relative population doubling, relative increase in cell counts and relative cell counts for treatments in the absence of cytokinesis block, and replication index or cytokinesis blocked proliferation index in the presence of cytokinesis block. All of the chemicals tested gave significant increases in the percentage of micronucleated cells with and without cytokinesis block at concentrations giving approximately 60% toxicity (cytostasis and cell death) or less by all of the toxicity measures used. The outcomes from this series of tests support the use of relative increase in cell counts and relative population doubling, as well as relative cell counts, as appropriate measures of cytotoxicity for the non-cytokinesis blocked in the in vitro micronucleus assay.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206291     DOI: 10.1016/j.mrgentox.2010.02.016

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

2.  BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes.

Authors:  Hiroyuki Sasanuma; Masataka Tsuda; Suguru Morimoto; Liton Kumar Saha; Md Maminur Rahman; Yusuke Kiyooka; Haruna Fujiike; Andrew D Cherniack; Junji Itou; Elsa Callen Moreu; Masakazu Toi; Shinichiro Nakada; Hisashi Tanaka; Ken Tsutsui; Shintaro Yamada; Andre Nussenzweig; Shunichi Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

3.  Genetic Evidence for the Involvement of Mismatch Repair Proteins, PMS2 and MLH3, in a Late Step of Homologous Recombination.

Authors:  Md Maminur Rahman; Mohiuddin Mohiuddin; Islam Shamima Keka; Kousei Yamada; Masataka Tsuda; Hiroyuki Sasanuma; Jessica Andreani; Raphael Guerois; Valérie Borde; Jean-Baptiste Charbonnier; Shunichi Takeda
Journal:  J Biol Chem       Date:  2020-10-02       Impact factor: 5.157

4.  Incorporation of metabolic activation potentiates cyclophosphamide-induced DNA damage response in isogenic DT40 mutant cells.

Authors:  Kiyohiro Hashimoto; Shunichi Takeda; James A Swenberg; Jun Nakamura
Journal:  Mutagenesis       Date:  2015-06-17       Impact factor: 3.000

5.  Genetic evidence for the involvement of mismatch repair proteins, PMS2 and MLH3, in a late step of homologous recombination.

Authors:  Md Maminur Rahman; Mohiuddin Mohiuddin; Islam Shamima Keka; Kousei Yamada; Masataka Tsuda; Hiroyuki Sasanuma; Jessica Andreani; Raphael Guerois; Valerie Borde; Jean-Baptiste Charbonnier; Shunichi Takeda
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

6.  PDIP38/PolDIP2 controls the DNA damage tolerance pathways by increasing the relative usage of translesion DNA synthesis over template switching.

Authors:  Masataka Tsuda; Saki Ogawa; Masato Ooka; Kaori Kobayashi; Kouji Hirota; Mitsuo Wakasugi; Tsukasa Matsunaga; Tetsushi Sakuma; Takashi Yamamoto; Shunsuke Chikuma; Hiroyuki Sasanuma; Michelle Debatisse; Aidan J Doherty; Robert P Fuchs; Shunichi Takeda
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

7.  Transforming early pharmaceutical assessment of genotoxicity: applying statistical learning to a high throughput, multi end point in vitro micronucleus assay.

Authors:  Amy Wilson; Piotr Grabowski; Joanne Elloway; Stephanie Ling; Jonathan Stott; Ann Doherty
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

8.  Amelioration of Cadmium-Produced Teratogenicity and Genotoxicity in Mice Given Arthrospira maxima (Spirulina) Treatment.

Authors:  Nancy Argüelles-Velázquez; Isela Alvarez-González; Eduardo Madrigal-Bujaidar; Germán Chamorro-Cevallos
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-28       Impact factor: 2.629

9.  The role of the Mre11-Rad50-Nbs1 complex in double-strand break repair-facts and myths.

Authors:  Shunichi Takeda; Nguyen Ngoc Hoa; Hiroyuki Sasanuma
Journal:  J Radiat Res       Date:  2016-06-15       Impact factor: 2.724

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.